scholarly journals Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA

2015 ◽  
pp. 1223 ◽  
Author(s):  
Zhenyu Shao ◽  
Jingyu Shao ◽  
Bingxu Tan ◽  
Shanghui Guan ◽  
Zhulong Liu ◽  
...  
Nanoscale ◽  
2021 ◽  
Author(s):  
Debin Zheng ◽  
Jingfei Liu ◽  
Yinghao Ding ◽  
Limin Xie ◽  
Yingying Zhang ◽  
...  

In situ self-assembling of prodrug molecules into nanomedicine can elevate the therapeutic efficacy of anticancer medications by enhancing the targeting and enrichment of anticancer drugs at tumor sites. However, the...


2020 ◽  
Vol 20 (16) ◽  
pp. 1883-1894
Author(s):  
Yuan-Rong Liu ◽  
Ping-Yu Wang ◽  
Ning Xie ◽  
Shu-Yang Xie

MicroRNAs (miRNAs) are short, non-coding RNA molecules that regulate gene expression by translational repression or deregulation of messenger RNAs. Accumulating evidence suggests that miRNAs play various roles in the development and progression of lung cancers. Although their precise roles in targeted cancer therapy are currently unclear, miRNAs have been shown to affect the sensitivity of tumors to anticancer drugs. A large number of recent studies have demonstrated that some anticancer drugs exerted antitumor activities by affecting the expression of miRNAs and their targeted genes. These studies have elucidated the specific biological mechanism of drugs in tumor suppression, which provides a new idea or basis for their clinical application. In this review, we summarized the therapeutic mechanisms of drugs in lung cancer therapy through their effects on miRNAs and their targeted genes, which highlights the roles of miRNAs as targets in lung cancer therapy.


Author(s):  
Mei Jiang ◽  
Yuchen Lin ◽  
Xiaocui Fang ◽  
Mingpeng Liu ◽  
Lilusi Ma ◽  
...  

A novel delivery system for cisplatin based on electrostatics-mediated assemblies of gold nanoclusters and PEGylated cationic peptide was constructed. The constructed cisplatin@GC-pKs showed much enhanced anti-tumor activity for lung cancer therapy.


2015 ◽  
Vol 34 (2) ◽  
pp. 291-301 ◽  
Author(s):  
Dalit Landesman-Milo ◽  
Srinivas Ramishetti ◽  
Dan Peer

Cell Cycle ◽  
2007 ◽  
Vol 6 (17) ◽  
pp. 2178-2185 ◽  
Author(s):  
Anwesha Dey ◽  
E.T. Wong ◽  
P. Bist ◽  
V. Tergaonkar ◽  
David Lane

2021 ◽  
Vol 10 (4) ◽  
pp. 75
Author(s):  
A.A. Izmailov ◽  
A.F. Nasretdinov ◽  
A.V. Sultanbaev ◽  
D.D. Sakaeva ◽  
K.V. Menshikov ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document